DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF A 4-WEEK TREATMENT WITH ORAL DOSES OF MEN15596 IN IRRITABLE BOWEL SYNDROME

Update Il y a 4 ans
Reference: EUCTR2008-000214-71

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of three doses of MEN 15596 on IBS symptoms relief as compared to placebo in a broad population of irritable bowel syndrome (IBS) patients following a 4 week oral treatment.


Inclusion criteria

  • Irritable bowel syndrome